Post # Biotech Values 29434 Economics of NVS collaboration 31875 Dr Pockros on NM283 and other HCV drugs 36268 (Biotech Values) Tyseka Sales Projections 36390 IDIX Pre-AASLD and 3Qtr 06 CC notes 37195 Proposed NM283 P3 trial design
Post # Idenix Pharmaceuticals 50 HCV Treatment Evolution 1989-2015
The creation of a thousand forests is in one acorn.